GenScript’s Post

Check out the 3rd session of our webinar series, “Harnessing iNKT cells for ‘off-the-shelf’ cancer therapy” presented by Dr. Lil Yang, Associate Professor at the University of California. This presentation describes a study combining hematopoietic stem cell (HSC) gene engineering and in vitro differentiation, to generate human allogeneic HSC-engineered iNKT (AlloHSC-iNKT) cells at high yield and purity. These cells closely resemble endogenous iNKT cells, effectively target tumor cells using multiple mechanisms, and exhibit high safety and low immunogenicity. Collectively, these preclinical studies demonstrate the feasibility and cancer therapy potential of AlloHSC-iNKT cell products and lay a foundation for their translational and clinical development. Watch here! https://lnkd.in/gkrz3d82 #cancerresearch #syntheticbiology #lifesciences #rnatherapeutics #geneandcellresearch